Insights
Leadership Styles For Pharmaceutical Executives
The pharmaceutical industry is a demanding and challenging environment for executive leaders, pressured by regulatory shifts, digital transformation, global supply
CEO Onboarding – A Comprehensive Guide
The appointment of a new CEO is a critical moment in the life of any organisation. Whether it’s a startup
Generics and the Importance of Marketing
Generic medicines have been proven to be just as safe and effective as their branded counterparts, but despite this, they
5 key strategies for hiring a CEO
Hiring a CEO is probably the most business-critical decision you’ll ever make. It puts tremendous pressure on your board of
What leadership styles are best for pharma execs
What makes a good pharmaceutical executive? The core responsibilities are clear: they must be able to analyse and develop their
How Will Tech Affect Pharmaceutical Sales in 2023
Technology is key for pharmaceutical companies, crucial for all aspects of the way they do business- from the discovery of
- All Posts
- Biosimilars
- Executive Search
- Generics
- Hiring
- HR
- Leadership
- Wellbeing
Introduction “Biosimilar” medicines are characteristically different from generic medicines because of their molecular size and structure, together with the sheer complexity and cost of their development. For example, a 500mg...
Companies are increasingly using psychometric tests to assess and ensure they recruit the right executives to bring positive change to their businesses. It brings a scientific element to executive recruitment...
This week is national stress awareness week and we have seen a lot of articles on how to help ease and remove stress for employees within a business but very...
Branded products are certainly good for the brand owner’s bottom line–but are they good for the consumer? Current received wisdom says no. As Naomi Klein argued in No Logo, greater access to...
There are a lot of major advancements linked to biological medicines, including many pathological conditions such as autoimmune diseases and cancer. Biosimilars, a lower cost alternative to many biological medicines,...
The COVID-19 pandemic had a huge impact on the pharmaceutical industry; it disrupted supply chains, delayed production and led to a shortage of medicines. In fact, it’s estimated that close...
If you think there’s too much red tape in your industry, spare a thought for pharma. Pharma manufacturers are subject to 76,000 restrictions–and with patients’ lives on the line, they...
Back in 2020, the worldwide pharmaceutical market had a value of $1.27 trillion; $387.92 billion and $28.235 billion of this was made up of the generics market and biosimilars market...